These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16213406)

  • 1. Type 3 Gaucher's disease in a three-year-old child: saccadic eye movements analysis.
    Accardo A; Bembi B; Pensiero S; Perissutti P
    J AAPOS; 2005 Oct; 9(5):501-3. PubMed ID: 16213406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saccadic analysis for early identification of neurological involvement in Gaucher disease.
    Accardo AP; Pensiero S; Perissutti P
    Ann N Y Acad Sci; 2005 Apr; 1039():503-7. PubMed ID: 15827009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular motor abnormalities in Gaucher disease.
    Harris CM; Taylor DS; Vellodi A
    Neuropediatrics; 1999 Dec; 30(6):289-93. PubMed ID: 10706022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infantile Nystagmus and Abnormalities of Conjugate Eye Movements in Down Syndrome.
    Weiss AH; Kelly JP; Phillips JO
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1301-9. PubMed ID: 26998716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
    Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, controlled trial of miglustat in Gaucher's disease type 3.
    Schiffmann R; Fitzgibbon EJ; Harris C; DeVile C; Davies EH; Abel L; van Schaik IN; Benko W; Timmons M; Ries M; Vellodi A
    Ann Neurol; 2008 Nov; 64(5):514-22. PubMed ID: 19067373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adult Gaucher's disease with pulmonary involvement].
    Jarnvig IL; Milman N; Jacobsen GK; Kassis E
    Ugeskr Laeger; 1991 Sep; 153(40):2832-4. PubMed ID: 1926620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaucher disease and its treatment options.
    Bennett LL; Mohan D
    Ann Pharmacother; 2013 Sep; 47(9):1182-93. PubMed ID: 24259734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latency of saccades, vergence and combined saccade vergence movements in a subject with manifest latent nystagmus.
    Kapoula Z; Le Bertre H; Yang Q; Bucci MP
    Strabismus; 2004 Sep; 12(3):157-67. PubMed ID: 15370523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waveform characteristics of manifest latent nystagmus.
    Abadi RV; Scallan CJ
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3805-17. PubMed ID: 11053280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saccadic Impairments in Patients with the Norrbottnian Form of Gaucher's Disease Type 3.
    Blume J; Beniaminov S; Kämpe Björkvall C; Machaczka M; Svenningsson P
    Front Neurol; 2017; 8():295. PubMed ID: 28690585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired gait kinematics in type 1 Gaucher's Disease.
    Sorrentino P; Barbato A; Del Gaudio L; Rucco R; Varriale P; Sibilio M; Strazzullo P; Sorrentino G; Agosti V
    J Parkinsons Dis; 2016; 6(1):191-5. PubMed ID: 26756743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease.
    Schiffmann R; Heyes MP; Aerts JM; Dambrosia JM; Patterson MC; DeGraba T; Parker CC; Zirzow GC; Oliver K; Tedeschi G; Brady RO; Barton NW
    Ann Neurol; 1997 Oct; 42(4):613-21. PubMed ID: 9382473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management.
    Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R
    Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subarachnoid anesthesia in a patient with type I Gaucher disease.
    García Collada JC; Pereda Marín RM; Martínez AI; Miralles Serrano EM; Pacheco López JF
    Acta Anaesthesiol Scand; 2003 Jan; 47(1):106-9. PubMed ID: 12492809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaucher's disease: rare presentation of a rare disease.
    Shrestha B; Devgan A; Sharma M
    J Child Neurol; 2013 Oct; 28(10):1296-8. PubMed ID: 22914376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uveitis in Gaucher disease.
    Dweck A; Rozenman J; Ronen S; Zimran A; Elstein D
    Am J Ophthalmol; 2005 Jul; 140(1):146-7. PubMed ID: 16038664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deterioration of the auditory brainstem response in children with type 3 Gaucher disease.
    Campbell PE; Harris CM; Vellodi A
    Neurology; 2004 Jul; 63(2):385-7. PubMed ID: 15277647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of Gaucher's disease associated with peripheral retinal ischemia].
    Jaime S; Dalmas MF
    J Fr Ophtalmol; 1989; 12(6-7):461-3. PubMed ID: 2636243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saccadic instabilities in albinism without nystagmus.
    Timms C; Thompson D; Russell-Eggitt I; Clement R
    Exp Brain Res; 2006 Oct; 175(1):45-9. PubMed ID: 16718432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.